FDA Approves First Biosimilar Drug for Treatment of Wet AMD

Posted on November 29, 2021November 29, 2021 by Dan Roberts

November 29, 2021

FDA Approves First Biosimilar Drug for Treatment of Wet AMD

The U.S. Food and Drug Administration (FDA) has approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of wet AMD. Byooviz is also approved to treat macular edema and myopic choroidal neovascularization, a vision-threatening complication of myopia (nearsightedness). The drug is administered by intravitreal injection (delivered into the vitreous humor […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Posted on October 22, 2021October 22, 2021 by Dan Roberts

October 22, 2021

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Susvimo, previously called Port Delivery System with ranibizumab, is the first wet AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month. By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with wet AMD maintain their vision with as […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

New AMD Treatments Coming Soon

Posted on May 16, 2021May 16, 2021 by Dan Roberts

May 16, 2021

New AMD Treatments Coming Soon

Sometimes it seems that retina research moves at a snail’s pace, but science is steadily moving toward those treatments and cures that will keep our eyes healthy. This is an update on four therapeutics just around the corner for treatment of age-related macular degeneration (AMD). Of the hundreds of ongoing clinical trials for both wet […]

Also posted in

Don’t Blame Everything On Your Macula

Posted on March 17, 2021March 17, 2021 by Dan Roberts

March 17, 2021

Don’t Blame Everything On Your Macula

So your sight is slowly diminishing, and your ophthalmologist told you that nothing could be done. They said that the cells in the very center of your retina (the macula) are degenerating, and gradual loss of clear eyesight is to be expected. Still, they want to see you at least once a year unless you […]

Also posted in

Newest Sustained-Release Anti-VEGF Drug in Trials

Posted on January 29, 2021January 29, 2021 by Dan Roberts

January 29, 2021

Newest Sustained-Release Anti-VEGF Drug in Trials

EyePoint Pharmaceuticals, Inc. announced on January 28, 2021 that the first patient has been dosed in their Phase 1 clinical trial of EYP-1901. EYP-1901 is a potential twice-yearly sustained delivery intravitreal anti-VEGF treatment for wet age-related macular degeneration (wAMD). It is the newest of several sustained delivery drugs under study, this one promising to extend […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

News & Archive Categories

Category: Therapies, Treatments, and Procedures

FDA Approves First Biosimilar Drug for Treatment of Wet AMD